Literature DB >> 27388458

Factors associated with consistent condom use and STIs among foreign female entertainment workers: results from a cross-sectional survey in Singapore.

Raymond Boon Tar Lim1, Mee Lian Wong1, Olive N Y Cheung1, Dede Kam Tyng Tham1, Bee Choo Tai1, Roy Chan1,2.   

Abstract

OBJECTIVES: We assessed the prevalence of consistent condom use and laboratory-confirmed STIs among foreign female entertainment workers (FEWs) who engaged in paid or casual sex in Singapore and the factors associated with these characteristics.
METHODS: A cross-sectional survey, using time-location sampling, was conducted on 220 FEWs (115 Vietnamese and 105 Thai) in 2015. For multivariable analysis, we used a mixed-effects Poisson regression model with backward stepwise approach to account for clustering by venue and to obtain the adjusted prevalence ratios (aPRs) of factors associated with consistent condom use and STI positivity, respectively.
RESULTS: Consistent condom use with paid or casual partners in the past month was 39.6% and 36.2% for vaginal and oral sex, respectively. The prevalence of STI (cervical chlamydia, cervical gonorrhoea or pharyngeal gonorrhoea) positivity was 13.6%. In multivariable analysis, consistent condom use for both vaginal and oral sex increased with high self-perceived risk of getting STI/HIV (vaginal: aPR 2.09; 95% CI 1.26 to 3.46; oral: aPR 2.41; 95% CI 1.23 to 4.69) and condom negotiation (vaginal: aPR 3.74; 95% CI 2.07 to 6.75; oral: aPR 2.81; 95% CI 1.51 to 5.26). STI positivity decreased with consistent condom use for vaginal sex (aPR 0.22; 95% CI 0.07 to 0.75) and increased with number of sexual partners (aPR 1.43; 95% CI 1.07 to 1.92).
CONCLUSION: In addition to advocating for policy decisions to provide a safer work environment, behavioural interventions on condom negotiation skills and condom use and biomedical interventions on STI/HIV testing and treatment interventions are needed among the FEWs in Singapore. TRIAL REGISTRATION NUMBER: NCT02780986; pre-results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  BACTERIAL INFECTION; COMMERCIAL SEX; CONDOMS; PUBLIC HEALTH; SEXUAL BEHAVIOUR

Mesh:

Year:  2016        PMID: 27388458     DOI: 10.1136/sextrans-2015-052530

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  4 in total

1.  What are the factors associated with human immunodeficiency virus/sexually transmitted infection screening behaviour among heterosexual men patronising entertainment establishments who engaged in casual or paid sex? - Results from a cross-sectional survey in an Asian urban setting.

Authors:  Raymond Boon Tar Lim; Dede Kam Tyng Tham; Olive N Y Cheung; Bee Choo Tai; Roy Chan; Mee Lian Wong
Journal:  BMC Infect Dis       Date:  2016-12-19       Impact factor: 3.090

2.  Using qualitative and community-based engagement approaches to gain access and to develop a culturally appropriate STI prevention intervention for foreign female entertainment workers in Singapore.

Authors:  Raymond Boon Tar Lim; Olive N Y Cheung; Dede Kam Tyng Tham; Hanh Hao La; Thein Than Win; Roy Chan; Mee Lian Wong
Journal:  Global Health       Date:  2018-04-16       Impact factor: 4.185

3.  Sexually transmitted infections in male heterosexual Dutch clients who visited German cross-border female sex workers; a 3 year retrospective study.

Authors:  Carolina J G Kampman; Christian J P A Hoebe; René Koene; Laura Kamp; Klaus Jansen; Femke D H Koedijk; Alma Tostmann; Jeannine L A Hautvast
Journal:  BMC Public Health       Date:  2020-07-29       Impact factor: 3.295

4.  Premarital sex and condom use among trainee healthcare workers: an exploratory study of selected healthcare training institutions in Enugu State, Nigeria.

Authors:  Obinna Ositadimma Oleribe; Obehi Hilda Okojie; Nicholas Jonathan Burstow; Simon David Taylor-Robinson
Journal:  Pan Afr Med J       Date:  2019-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.